Safety and tolerability of natural and synthetic cannabinoids in adults aged over 50 years: A systematic review and meta-analysis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety and tolerability of natural and synthetic cannabinoids in adults aged over 50 years: A systematic review and meta-analysis
Authors
Keywords
Cannabinoids, Randomized controlled trials, Adverse events, Elderly, Medical risk factors, Metaanalysis, Multiple sclerosis, Cannabis
Journal
PLOS MEDICINE
Volume 18, Issue 3, Pages e1003524
Publisher
Public Library of Science (PLoS)
Online
2021-03-30
DOI
10.1371/journal.pmed.1003524
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of short-term cannabidiol treatment on response to social stress in subjects at clinical high risk of developing psychosis
- (2020) E. Appiah-Kusi et al. PSYCHOPHARMACOLOGY
- Non‐motor symptoms in Parkinson´s disease are reduced by nabilone
- (2020) Marina Peball et al. ANNALS OF NEUROLOGY
- Randomized placebo controlled trial of nabilone for agitation in Alzheimer's disease
- (2019) Nathan Herrmann et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Medical Cannabis for Older Patients—Treatment Protocol and Initial Results
- (2019) Ran Abuhasira et al. Journal of Clinical Medicine
- Epidemiological characteristics, safety and efficacy of medical cannabis in the elderly
- (2018) Ran Abuhasira et al. European Journal of Internal Medicine
- Sativex® as Add-on therapy Vs. further optimized first-line ANTispastics (SAVANT) in resistant multiple sclerosis spasticity: a double-blind, placebo-controlled randomised clinical trial
- (2018) Jolana Markovà et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Results of a Double-Blind, Randomized, Placebo-Controlled Study of Nabiximols Oromucosal Spray as an Adjunctive Therapy in Advanced Cancer Patients with Chronic Uncontrolled Pain
- (2018) Aron H. Lichtman et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Effect of Cannabidiol on Medial Temporal, Midbrain, and Striatal Dysfunction in People at Clinical High Risk of Psychosis
- (2018) Sagnik Bhattacharyya et al. JAMA Psychiatry
- Medical Use of Cannabinoids
- (2018) Ana Isabel Fraguas-Sánchez et al. DRUGS
- An update on the clinical consequences of polypharmacy in older adults: a narrative review
- (2018) Jonas W. Wastesson et al. Expert Opinion On Drug Safety
- Medical cannabis use in older patients: Update on medical knowledge
- (2018) Olivier Beauchet MATURITAS
- Safety and efficacy of nabiximols on spasticity symptoms in patients with motor neuron disease (CANALS): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial
- (2018) Nilo Riva et al. LANCET NEUROLOGY
- Pharmacotherapy of Apnea by Cannabimimetic Enhancement, the PACE Clinical Trial: Effects of Dronabinol in Obstructive Sleep Apnea
- (2017) David W Carley et al. SLEEP
- Pharmacotherapy of Apnea by Cannabimimetic Enhancement, the PACE Clinical Trial: Effects of Dronabinol in Obstructive Sleep Apnea
- (2017) David W Carley et al. SLEEP
- Effects on Spasticity and Neuropathic Pain of an Oral Formulation of Δ9-tetrahydrocannabinol in Patients WithProgressive Multiple Sclerosis
- (2017) Guido van Amerongen et al. CLINICAL THERAPEUTICS
- Therapeutic Potential of Cannabinoids in Psychosis
- (2016) F. Markus Leweke et al. BIOLOGICAL PSYCHIATRY
- Single dose delta-9-tetrahydrocannabinol in chronic pancreatitis patients: analgesic efficacy, pharmacokinetics and tolerability
- (2016) Marjan de Vries et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study
- (2016) Khalid A. Jadoon et al. DIABETES CARE
- Small-Sample Methods for Cluster-Robust Variance Estimation and Hypothesis Testing in Fixed Effects Models
- (2016) James E. Pustejovsky et al. JOURNAL OF BUSINESS & ECONOMIC STATISTICS
- Pharmacotherapy in the ageing patient: The impact of age per se (A review)
- (2015) Shamsher Singh et al. AGEING RESEARCH REVIEWS
- Tetrahydrocannabinol in Behavioral Disturbances in Dementia: A Crossover Randomized Controlled Trial
- (2015) Geke A.H. van den Elsen et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Cannabidiol (CBD) and its analogs: a review of their effects on inflammation
- (2015) Sumner Burstein BIOORGANIC & MEDICINAL CHEMISTRY
- Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: A randomised, double-blind, placebo-controlled study in cannabis users
- (2015) Chandni Hindocha et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Cannabinoids for Medical Use
- (2015) Penny F. Whiting et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Mortality Risk of Conventional Antipsychotics in Elderly Patients: A Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials
- (2015) Tessa A. Hulshof et al. Journal of the American Medical Directors Association
- Tetrahydrocannabinol for neuropsychiatric symptoms in dementia: A randomized controlled trial
- (2015) G. A. H. van den Elsen et al. NEUROLOGY
- Safety, pharmacodynamics, and pharmacokinetics of multiple oral doses of delta-9-tetrahydrocannabinol in older persons with dementia
- (2015) Amir I. A. Ahmed et al. PSYCHOPHARMACOLOGY
- Conducting Meta-Analyses inRwith themetaforPackage
- (2015) Wolfgang Viechtbauer Journal of Statistical Software
- Efficacy and safety of medical cannabinoids in older subjects: A systematic review
- (2014) G.A.H. van den Elsen et al. AGEING RESEARCH REVIEWS
- Therapeutic Potential of Cannabinoids in Neurodegenerative Disorders: A Selective Review
- (2014) Latha Velayudhan et al. CURRENT PHARMACEUTICAL DESIGN
- A double-blind, randomized, placebo-controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatment
- (2014) M. Serpell et al. EUROPEAN JOURNAL OF PAIN
- Safety and pharmacokinetics of oral delta-9-tetrahydrocannabinol in healthy older subjects: A randomized controlled trial
- (2014) Amir I.A. Ahmed et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- The prevalence and incidence of medicinal cannabis on prescription in The Netherlands
- (2013) Arno Hazekamp et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- A Double-Blind, Placebo-Controlled, Crossover Pilot Trial With Extension Using an Oral Mucosal Cannabinoid Extract for Treatment of Chemotherapy-Induced Neuropathic Pain
- (2013) Mary E. Lynch et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial
- (2013) John Zajicek et al. LANCET NEUROLOGY
- MUltiple Sclerosis and Extract of Cannabis: results of the MUSEC trial
- (2012) John Peter Zajicek et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Nabiximols for Opioid-Treated Cancer Patients With Poorly-Controlled Chronic Pain: A Randomized, Placebo-Controlled, Graded-Dose Trial
- (2012) Russell K. Portenoy et al. JOURNAL OF PAIN
- Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment
- (2012) Amir Englund et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study
- (2012) Karen Barnett et al. LANCET
- An enriched-enrolment, randomized withdrawal, flexible-dose, double-blind, placebo-controlled, parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic peripheral neuropathic pain
- (2012) Cory Toth et al. PAIN
- Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial
- (2011) T. D. Brisbois et al. ANNALS OF ONCOLOGY
- GRADE guidelines: 3. Rating the quality of evidence
- (2011) Howard Balshem et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Randomized, Controlled Crossover Trial of Dronabinol, 2.5 mg, for Agitation in 2 Patients With Dementia
- (2011) Sebastian Walther et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex® (nabiximols)
- (2011) W Notcutt et al. Multiple Sclerosis Journal
- Cannabinoid effects on ventilation and breathlessness: A pilot study of efficacy and safety
- (2011) Elspeth E Pickering et al. Chronic Respiratory Disease
- The Effects of Nabilone on Sleep in Fibromyalgia: Results of a Randomized Controlled Trial
- (2010) Mark A. Ware et al. ANESTHESIA AND ANALGESIA
- Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting
- (2010) Marta Duran et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Tetrahydrocannabinol (THC) for cramps in amyotrophic lateral sclerosis: a randomised, double-blind crossover trial
- (2010) M. Weber et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
- (2010) José Alexandre S Crippa et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Modulation of Mediotemporal and Ventrostriatal Function in Humans by Δ9-Tetrahydrocannabinol
- (2009) Sagnik Bhattacharyya et al. ARCHIVES OF GENERAL PSYCHIATRY
- Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study of the Efficacy, Safety, and Tolerability of THC:CBD Extract and THC Extract in Patients with Intractable Cancer-Related Pain
- (2009) Jeremy R. Johnson et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- A pilot study using nabilone for symptomatic treatment in Huntington's disease
- (2009) Adrienne Curtis et al. MOVEMENT DISORDERS
- Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology
- (2009) Sagnik Bhattacharyya et al. NEUROPSYCHOPHARMACOLOGY
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- Adverse effects of medical cannabinoids: a systematic review
- (2008) T. Wang et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
- (2008) Gordon H Guyatt et al. BMJ-British Medical Journal
- The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin
- (2007) R G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started